IRIS
SALVATORE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.479
NA - Nord America 5.103
EU - Europa 4.502
SA - Sud America 737
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AN - Antartide 1
Totale 16.022
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.887
SG - Singapore 2.504
RU - Federazione Russa 1.791
IT - Italia 1.239
CN - Cina 954
VN - Vietnam 953
BR - Brasile 600
HK - Hong Kong 477
DE - Germania 262
UA - Ucraina 238
FR - Francia 201
FI - Finlandia 174
NL - Olanda 170
CA - Canada 132
BD - Bangladesh 125
GB - Regno Unito 122
IN - India 103
JP - Giappone 79
AR - Argentina 61
CI - Costa d'Avorio 58
IE - Irlanda 54
ZA - Sudafrica 54
ES - Italia 46
PL - Polonia 44
SE - Svezia 43
MX - Messico 41
KR - Corea 38
IQ - Iraq 31
TR - Turchia 31
AT - Austria 29
PH - Filippine 28
ID - Indonesia 24
PK - Pakistan 19
TH - Thailandia 18
CO - Colombia 17
TW - Taiwan 17
BE - Belgio 16
EC - Ecuador 16
NG - Nigeria 15
SA - Arabia Saudita 12
UZ - Uzbekistan 12
VE - Venezuela 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
HN - Honduras 9
MA - Marocco 9
MY - Malesia 9
KE - Kenya 8
LT - Lituania 8
SK - Slovacchia (Repubblica Slovacca) 8
EG - Egitto 7
SN - Senegal 7
BG - Bulgaria 6
CH - Svizzera 6
JO - Giordania 6
UY - Uruguay 6
BO - Bolivia 5
DK - Danimarca 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
CL - Cile 4
AL - Albania 3
AU - Australia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
KW - Kuwait 3
NI - Nicaragua 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CR - Costa Rica 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 15.997
Salva come PNG Salva come JPEG
Città #
Singapore 1.147
San Jose 756
Hong Kong 459
Ashburn 444
Moscow 428
Naples 401
Ho Chi Minh City 290
Chandler 284
Beijing 269
Jacksonville 219
Hanoi 207
Santa Clara 182
Amsterdam 139
Hefei 135
Los Angeles 132
Lauterbourg 127
Millbury 116
The Dalles 96
Napoli 95
Boston 94
New York 90
Princeton 86
Munich 78
Buffalo 77
Wilmington 63
São Paulo 61
Council Bluffs 57
Tokyo 57
Nanjing 56
Dallas 50
Turku 48
Haiphong 47
Ottawa 46
Orem 45
Redondo Beach 44
Lawrence 42
Des Moines 37
Houston 35
Rome 34
Warsaw 34
Milan 33
Da Nang 32
Chicago 31
Montreal 31
Brooklyn 30
Nuremberg 30
Helsinki 27
Phoenix 26
Seattle 26
Johannesburg 25
Toronto 25
Frankfurt am Main 24
Salerno 24
Seoul 24
Stockholm 24
Kochi 23
Norwalk 23
Poplar 22
Atlanta 20
Chennai 20
Hebei 20
Shenyang 20
Denver 19
Mexico City 19
San Giovanni Rotondo 19
Nanchang 17
Rio de Janeiro 17
Belo Horizonte 16
Dong Ket 16
San Francisco 15
Washington 15
Abuja 14
London 14
Thái Nguyên 14
Ann Arbor 13
Florence 13
Santa Maria 13
Santa Maria Capua Vetere 13
Tianjin 13
Afragola 12
Boardman 12
Curitiba 12
Lappeenranta 12
Okayama 12
Ottaviano 12
Vienna 12
Can Tho 11
Changsha 11
Hải Dương 11
Shanghai 11
Thái Bình 11
Aversa 10
Biên Hòa 10
Tashkent 10
Woodbridge 10
Avellino 9
Bangkok 9
Brasília 9
Casoria 9
Charlotte 9
Totale 8.151
Salva come PNG Salva come JPEG
Nome #
Spot-light on microbiota in obesity and cancer 212
Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch 199
The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress 198
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi 194
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells 189
Exposure to artificial light at night: A common link for obesity and cancer? 188
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 187
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 186
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 181
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling 177
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 171
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 171
Deiodinases and their intricate role in thyroid hormone homeostasis 170
Thyroid hormone enhances angiogenesis and the warburg effect in squamous cell carcinomas 170
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice 168
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence 163
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 160
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 158
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 156
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 153
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 153
Calcium interaction with bovine Thyroglobulin: Stoichiometry and structural consequences of calcium binding. 152
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 147
Author Correction: Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch (Nature Communications, (2019), 10, 1, (5410), 10.1038/s41467-019-13140-2) 146
Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences 145
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 141
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 140
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 139
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients 132
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells 132
Advances in functional imaging of differentiated thyroid cancer 131
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results 130
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 129
A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk during Skeletal Muscle Regeneration 129
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib 128
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 127
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis 127
Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression 127
Identification and functional characterization of a novel mutation in the NKX2-1 gene: Comparison with the data in the literature 127
Thyroid hormone action in muscle atrophy 126
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. 125
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. 125
Type 3 deiodinase and solid tumors: an intriguing pair. 125
Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis. 125
Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation 124
Methods and Products for Treating Proliferative Disorders. 124
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 123
Calcium interaction with bovine thyroiglobulin: stoichiometry and structural consequences of calcium binding 123
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer 123
Endemic goiter and iodine deficiency diffusion in province of Avellino 120
Identification and Functional Characterization of a Novel Mutation in theNKX2-1Gene: Comparison with the Data in the Literature 120
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 120
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3 118
A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice 118
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. 116
The relevance of T3 in the management of hypothyroidism 116
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 115
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 115
Widespread endemic goiter and iodine deficiency in the province of Avellino 114
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report 114
The importance of the RET gene in thyroid cancer and therapeutic implications 114
Transcription factor Nkx-2.5 induces sodium/iodidesymporter gene expression and participates in retinoic acid- andlactation-induced transcription in mammary cells. 111
Tiroide è Donna 111
The different cardiac expression of the Type 2 Iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to NKX-2.5 and GATA-4 transcription factors 110
Deiodinases in thyroid tumorigenesis 110
The selective loss of the Type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism 109
Deiodinases and Cancer 107
Role of type 3 deiodinase in cancer. 106
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome 106
CHERACTERIZATION OF THE 5'-FLANKING AND 5'UNTRANSLATED REGIONS OF THE CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-RESPONSIVE HUMAN TYPE 2 DEIODINASE GENE. 104
On the governance of incentives to innovate: Can Open Source models be applied to drug development? 104
APPROCCIO CLINICO AL PAZIENTE CON GOZZO 103
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. 103
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back 103
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next? 102
A 21 year old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase 101
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. 100
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism 99
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 99
PTC IN THYROID TUMORS 99
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27 rats 98
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. 98
Type 2 Iodothyronine Deiodinase Levels Are Higher in Slow-Twitch than Fast-Twitch Mouse Skeletal Muscle and Are Increased in Hypothyroidism 98
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 98
Pendrin is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells 97
Biochemistry, cellular and molecular biology, and physiological role of the iodothyronine selenodeiodinases 96
CLONING OF THE RAT TISSUE INHIBITOR OF METALLOPROTEINASE TYPE 2 (timp-2) GENE; ANALYSIS OF ITSEXPRESSION IN NORMAL AND TRASFORMED THYROID CELLS. 95
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 95
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. 95
FREQUENT RET PROTO-ONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (MEN2A). 94
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle 94
RET\PTC activation in human thyroid carcinomas 93
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 93
Deiodination in cancer growth: the role of type III deiodinase 92
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 91
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 91
MUTATION OF SECYS RESIDUE 266 IN HUMAN D2 SELENODEIODINASE ALTERS 75Se INCORPORATION WITHOUT AFFECTING THE BIOCHEMICAL PROPERTIES. 90
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 90
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 89
Isolated elevated sweat chloride concentrations in the presence of the rare mutation S1455X: an extremely mild form of CFTR dysfunction. 87
Totale 12.637
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022910 21 61 33 24 26 14 36 29 74 63 235 294
2022/2023906 138 76 24 34 88 80 7 62 143 138 61 55
2023/2024868 54 137 154 83 49 72 16 80 26 18 116 63
2024/20254.232 215 264 34 40 111 248 471 243 312 433 1.455 406
2025/20267.699 920 503 770 824 1.266 345 863 420 855 473 228 232
2026/2027185 185 0 0 0 0 0 0 0 0 0 0 0
Totale 16.243